CEVA |
E22020B

Salbute Injection

Enquire today to create an account

Register
Phenylbutazone and sodium salicylate are both nonsteroidal anti-inflammatory drugs (NSAIDs) with analgesic effects to relieve pain and antipyretic effects to relieve fever.

COMPOSITION:
Phenylbutazone 186 mg Sodium salicylate 50 mg

ACTIONS:
Phenylbutazone and sodium salicylate are both nonsteroidal anti-inflammatory drugs (NSAIDs) with analgesic effects to relieve pain and antipyretic effects to relieve fever. The rapid action of sodium salicylate combines with the longer-term activity of phenylbutazone to resent an excellent option for the treatment and management of musculoskeletal pain in horses. Phenylbutazone shows well documented and proven effectiveness in the treatment of musculoskeletal conditions in horses. Sodium salicylate is an antipyretic analgesic agent.

INDICATIONS
For the relief of musculoskeletal pain in horses. Suitable conditions for treatment include arthritis, arthrosis, bursitis, osteoarthritis, tendonitis, tenosynovitis and inflammation of the skin and soft tissues. When used as part of the management of febrile conditions, the underlying cause of the fever must also be treated.

WARNINGS
Contraindications: in horses with severe hepatic, renal or cardiac disease; gastrointestinal disease, particularly gastrointestinal ulceration and haemorrhage; history of blood disorders.
Adverse reactions: to phenylbutazone and sodium salicylate are rare however gastric irritation, jaundice, limb oedema and blood dyscrasias have been reported.
If used in performance animals, the regulations of the relevant authorities regarding medication should be observed.
Meat Withholding Period (Horses): NOT TO BE USED in horses intended for human consumption.
[Zebravet_Files]:
[Zebravet_Files]